(Q40518557)

English

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

scientific article published on October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

object named as

Larisa Rudenko

14

0 references

object named as

Irina Kiseleva

2

0 references

author name string

Thomas Palker

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kimberly Johnston

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Qin Su

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Timothy Toner

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Christopher Szymkowiak

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Wan-Sang Kwan

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Boris Rubin

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Luba Petrukhin

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Joan Wlochowski

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Juanita Monteiro

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Nikolai Kraiouchkine

12

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Daniel DiStefano

13

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alan Shaw

15

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rima Youil

16

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

183-194

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenza Immunization for Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Emerging infections: pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Host cell-mediated variation in H3N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Novel generations of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Adaptation and Growth Characteristics of Influenza Virus at 25° C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Molecular mapping of influenza virus RNA polymerase by site-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Evidence for host-cell selection of influenza virus antigenic variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The impact of influenza epidemics on hospitalizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Identifiers

10.1016/J.VIRUSRES.2004.05.009

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40518557&oldid=1899832417"